Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunotherapy, Adoptive | 20 | 2024 | 1270 | 2.310 |
Why?
|
| Hematologic Neoplasms | 4 | 2022 | 1832 | 0.950 |
Why?
|
| Graft vs Host Disease | 3 | 2022 | 2957 | 0.930 |
Why?
|
| Receptors, Antigen, T-Cell | 7 | 2024 | 2540 | 0.890 |
Why?
|
| Pulmonary Alveolar Proteinosis | 1 | 2022 | 42 | 0.830 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2023 | 5442 | 0.710 |
Why?
|
| Hematologic Diseases | 2 | 2023 | 498 | 0.700 |
Why?
|
| Communication Barriers | 1 | 2020 | 398 | 0.590 |
Why?
|
| Professional-Family Relations | 1 | 2020 | 482 | 0.560 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2022 | 3523 | 0.530 |
Why?
|
| Lymphoma, B-Cell | 1 | 2020 | 931 | 0.470 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2017 | 491 | 0.460 |
Why?
|
| T-Lymphocytes | 13 | 2023 | 10180 | 0.360 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2023 | 290 | 0.320 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2023 | 260 | 0.310 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 3229 | 0.290 |
Why?
|
| Communication | 1 | 2020 | 3749 | 0.280 |
Why?
|
| Glioblastoma | 4 | 2024 | 3481 | 0.270 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2727 | 0.260 |
Why?
|
| Interleukin-7 | 1 | 2023 | 142 | 0.230 |
Why?
|
| Transplantation Conditioning | 2 | 2020 | 1598 | 0.220 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2022 | 895 | 0.210 |
Why?
|
| Lymphoma | 2 | 2022 | 1877 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5535 | 0.190 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 297 | 0.180 |
Why?
|
| Hospital Departments | 1 | 2020 | 137 | 0.180 |
Why?
|
| Translating | 1 | 2020 | 144 | 0.170 |
Why?
|
| Pancytopenia | 1 | 2019 | 104 | 0.160 |
Why?
|
| Antineoplastic Agents | 2 | 2023 | 13695 | 0.160 |
Why?
|
| Cyclophosphamide | 2 | 2023 | 2242 | 0.150 |
Why?
|
| Lentivirus | 1 | 2020 | 501 | 0.150 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2019 | 207 | 0.150 |
Why?
|
| Transduction, Genetic | 1 | 2020 | 913 | 0.150 |
Why?
|
| Antibodies, Bispecific | 1 | 2019 | 164 | 0.150 |
Why?
|
| Neoplasms | 3 | 2023 | 21683 | 0.150 |
Why?
|
| Humans | 32 | 2024 | 744343 | 0.150 |
Why?
|
| Telephone | 1 | 2020 | 617 | 0.150 |
Why?
|
| Antigen-Presenting Cells | 1 | 2020 | 973 | 0.140 |
Why?
|
| Tandem Repeat Sequences | 1 | 2017 | 185 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2023 | 1861 | 0.120 |
Why?
|
| Drug Approval | 1 | 2020 | 742 | 0.120 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2021 | 1381 | 0.120 |
Why?
|
| Autoantibodies | 1 | 2022 | 2035 | 0.120 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2017 | 651 | 0.110 |
Why?
|
| Biological Products | 1 | 2022 | 860 | 0.110 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 1584 | 0.110 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 1378 | 0.110 |
Why?
|
| Bone Marrow Transplantation | 1 | 2019 | 2765 | 0.100 |
Why?
|
| Antigens, Neoplasm | 1 | 2019 | 1988 | 0.100 |
Why?
|
| Organoplatinum Compounds | 1 | 2012 | 408 | 0.100 |
Why?
|
| Hodgkin Disease | 1 | 2019 | 1415 | 0.100 |
Why?
|
| Antigens, CD19 | 2 | 2022 | 380 | 0.090 |
Why?
|
| Intensive Care Units | 1 | 2020 | 3679 | 0.070 |
Why?
|
| Skin | 1 | 2019 | 4364 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 11031 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2023 | 9274 | 0.070 |
Why?
|
| Multiple Myeloma | 1 | 2023 | 5181 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8642 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11524 | 0.060 |
Why?
|
| Disease Progression | 1 | 2020 | 13284 | 0.060 |
Why?
|
| Cytokines | 3 | 2023 | 7322 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5172 | 0.050 |
Why?
|
| France | 1 | 2023 | 517 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 7913 | 0.050 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 3176 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2023 | 1012 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2022 | 558 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2019 | 281 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 8863 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2012 | 4253 | 0.040 |
Why?
|
| Cell Death | 1 | 2022 | 1706 | 0.040 |
Why?
|
| United States | 2 | 2023 | 69872 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 2007 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 1836 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2023 | 16689 | 0.030 |
Why?
|
| Adult | 5 | 2023 | 214055 | 0.030 |
Why?
|
| Child | 2 | 2023 | 77709 | 0.030 |
Why?
|
| Exanthema | 1 | 2019 | 501 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 9239 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2019 | 1850 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2019 | 63114 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2019 | 77449 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2017 | 23403 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1276 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2022 | 3206 | 0.030 |
Why?
|
| Mutation | 1 | 2017 | 29786 | 0.030 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2012 | 234 | 0.030 |
Why?
|
| Fever | 1 | 2019 | 1616 | 0.030 |
Why?
|
| Hepatic Artery | 1 | 2012 | 245 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3557 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 4479 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3278 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2019 | 2948 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6756 | 0.020 |
Why?
|
| Aged | 4 | 2022 | 163280 | 0.020 |
Why?
|
| Cognition | 1 | 2023 | 6770 | 0.020 |
Why?
|
| Incidence | 1 | 2023 | 20947 | 0.020 |
Why?
|
| Middle Aged | 4 | 2022 | 213383 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12959 | 0.020 |
Why?
|
| Mice | 2 | 2019 | 81183 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11483 | 0.010 |
Why?
|
| Male | 4 | 2022 | 350118 | 0.010 |
Why?
|
| Animals | 2 | 2019 | 168757 | 0.010 |
Why?
|
| Female | 3 | 2022 | 380194 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 56430 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 85781 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 57776 | 0.000 |
Why?
|
Concepts
(107)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(75)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_